Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bone disease in primary hyperparathyroidism.

M Parisien1, S J Silverberg, E Shane

  • 1Department of Medicine, College of Physicians and Surgeons, Columbia University, New York, New York.

Endocrinology and Metabolism Clinics of North America
|March 1, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Revisiting the endocrine and metabolic manifestations of COVID-19 two years into the pandemic.

Reviews in endocrine & metabolic disorders·2022
Same author

In premenopausal women with idiopathic osteoporosis, lower bone formation rate is associated with higher body fat and higher IGF-1.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2021
Same author

A Simple Formula to Estimate Parathyroid Weight on 4D-CT, Predict Pathologic Weight, and Diagnose Parathyroid Adenoma in Patients with Primary Hyperparathyroidism.

AJNR. American journal of neuroradiology·2020
Same author

Consensus statement from 2<sup>nd</sup> International Conference on Controversies in Vitamin D.

Reviews in endocrine & metabolic disorders·2020
Same author

Hypercalciuria: its value as a predictive risk factor for nephrolithiasis in asymptomatic primary hyperparathyroidism?

Journal of endocrinological investigation·2019
Same author

Long-term denosumab treatment restores cortical bone loss and reduces fracture risk at the forearm and humerus: analyses from the FREEDOM Extension cross-over group.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2019
Same journal

Navigating Adrenal Disease: A Comprehensive, Practical Guide for the Clinician.

Endocrinology and metabolism clinics of North America·2026
Same journal

Adrenal Disorders in Pregnancy.

Endocrinology and metabolism clinics of North America·2026
Same journal

Diagnosis and Management of Adrenocortical Carcinoma.

Endocrinology and metabolism clinics of North America·2026
Same journal

Pheochromocytomas and Paragangliomas.

Endocrinology and metabolism clinics of North America·2026
Same journal

Hereditary Conditions Associated with Adrenocortical Carcinoma, Pheochromocytoma, and Other Adrenal Tumors: Genetic Testing and Management Recommendations.

Endocrinology and metabolism clinics of North America·2026
Same journal

Primary Bilateral Macronodular Adrenal Hyperplasia.

Endocrinology and metabolism clinics of North America·2026
See all related articles

Primary hyperparathyroidism, even when asymptomatic, affects bone health. Sensitive tests reveal parathyroid hormone

Area of Science:

  • Endocrinology
  • Bone Metabolism
  • Skeletal Health

Background:

  • Primary hyperparathyroidism (PHPT) historically caused severe bone disease (osteitis fibrosa cystica).
  • Modern PHPT often presents as asymptomatic hypercalcemia, with severe skeletal manifestations being rare.
  • Subtle skeletal changes may occur even without overt clinical symptoms.

Purpose of the Study:

  • To investigate the subclinical effects of excess parathyroid hormone on bone in mild PHPT.
  • To assess whether sensitive diagnostic techniques can detect skeletal alterations in asymptomatic patients.
  • To explore the implications of these findings for clinical management and surgical intervention.

Main Methods:

  • Utilized photon absorptiometry for bone density measurements.

Related Experiment Videos

  • Employed bone histomorphometry to analyze bone structure.
  • Focused on patients with mild PHPT and no overt skeletal symptoms.

    • Main Results:

    • Detected a deficit in cortical bone.
    • Observed preservation or increase in cancellous bone elements.
    • These changes were evident despite the absence of clinical skeletal disease.

    Conclusions:

    • Subtle but significant skeletal changes occur in mild PHPT, detectable by advanced methods.
    • The long-term clinical significance and therapeutic implications of these subclinical findings require further investigation.
    • Further data is needed to determine if these changes predict future bone disease or warrant surgical intervention.